AstraZeneca PLC is 137.6x more valuable than HUTCHMED (China) Ltd by market capitalization ($286.27 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HCM | AZN |
|---|---|---|
| Market cap | $2.08 B | $286.27 B |
| US-listed rank | #2074 | #45 |
| Revenue (latest FY) | $548.51M | - |
| Net income (latest FY) | $456.91M | - |
| Net margin | 83.3% | - |
| P/E (trailing FY) | 4.6 | - |
| SEC filings | 589 | 1,004 |
AstraZeneca PLC is 137.6x more valuable than HUTCHMED (China) Ltd by market capitalization ($286.27 B vs $2.08 B).
Full pages: HUTCHMED (China) Ltd and AstraZeneca PLC, or browse the full rankings.